Welcome to Central Library, SUST

Protein kinases as drug targets / (Record no. 62592)

MARC details
000 -LEADER
fixed length control field 04634cam a2200745Ka 4500
001 - CONTROL NUMBER
control field sulb-eb0030940
003 - CONTROL NUMBER IDENTIFIER
control field BD-SySUS
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20170713221242.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cn|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 110609s2011 gw a ob 001 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency DG1
Language of cataloging eng
Description conventions pn
Transcribing agency DG1
Modifying agency YDXCP
-- N$T
-- CDX
-- OCLCQ
-- OCLCO
-- OCLCQ
-- UWO
-- OCLCQ
-- OCLCA
-- NLGGC
-- IDEBK
-- OCLCQ
-- DEBBG
-- BD-SySUS
019 ## -
-- 756898492
-- 757403635
-- 759006763
-- 816865413
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783527633470
Qualifying information (electronic bk.)
International Standard Book Number 3527633472
Qualifying information (electronic bk.)
International Standard Book Number 9783527633487
Qualifying information (electronic bk.)
International Standard Book Number 3527633480
Qualifying information (electronic bk.)
International Standard Book Number 1283283247
International Standard Book Number 9781283283243
Canceled/invalid ISBN 9783527317905
Canceled/invalid ISBN 3527317902
024 8# - OTHER STANDARD IDENTIFIER
Standard number or code 9786613283245
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier AU@
System control number 000049641601
OCLC library identifier GBVCP
System control number 790033518
OCLC library identifier NZ1
System control number 15916500
OCLC library identifier DEBBG
System control number BV043393179
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)729724693
Canceled/invalid control number (OCoLC)756898492
-- (OCoLC)757403635
-- (OCoLC)759006763
-- (OCoLC)816865413
037 ## - SOURCE OF ACQUISITION
Stock number 10.1002/9783527633470
Source of stock number/acquisition Wiley InterScience
Note http://www3.interscience.wiley.com
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RM666.E548
Item number P76 2011
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number W1
Item number ME9613H v.49 2011
Classification number QU 143
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 071000
Source bisacsh
Subject category code TDCW
Source bicssc
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.798
Edition number 22
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Protein kinases as drug targets /
Statement of responsibility, etc. edited by Bert Klebl, Gerhard Müller, and Michael Hamacher.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc. Weinheim :
Name of publisher, distributor, etc. Wiley-VCH ;
Place of publication, distribution, etc. Chichester :
Name of publisher, distributor, etc. John Wiley [distributor],
Date of publication, distribution, etc. ©2011.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (xxi, 373 pages) :
Other physical details illustrations (some color).
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
490 1# - SERIES STATEMENT
Series statement Methods and principles in medicinal chemistry ;
Volume/sequential designation 49
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note In vitro characterization of small-molecule kinase inhibitors -- Screening for kinase inhibitors: from biochemical to cellular assays -- Dissecting phosphorylation networks: the use of analogue-sensitive kinases and more specific kinase inhibitors as tools -- Rational drug design of kinase inhibitors for signal transduction therapy -- Kinaes inhibitors in signal transduction therapy -- Design principles of deep pocket-targeting protein kinase inhibitors -- From discovery to clinic: aurora kinase inhibitors as novel treatments for cancer -- Discovery and design of protein kinase inhibitors: targeting the cell cycle in oncology -- Medicinal chemistry approaches for the inhibition of the p38 MAPK pathway -- Cellular protein kinases as antiviral targets -- Prospects for TB therapeutics targeting mycobacterium tuberculosis phosphosignaling networks.
588 0# - SOURCE OF DESCRIPTION NOTE
Source of description note Print version record.
520 ## - SUMMARY, ETC.
Summary, etc. With Kinase inhibitors being widely seen as the long-sought 'magic bullet' to conquer cancer, this fully comprehensive guide to kinase inhibitor drug development covers the entire drug pipeline from target identification to compound development and clinical application. Volume 1 focuses upon the medicinal chemistry of kinase drugs, from target identification to lead optimization, and contains numerous contributions from large and small pharmaceutical companies. Volume 2 surveys current and future therapeutic application areas for kinase inhibitor drugs, with a strong focus on oncology drugs, as this is the most important therapeutic field for these drugs. In addition, all six currently approved kinase inhibitor drugs (small molecules and antibodies) are described, and their performances in clinical practice are discussed.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Protein kinases
General subdivision Inhibitors.
Topical term or geographic name as entry element Antineoplastic agents
General subdivision Development.
Topical term or geographic name as entry element Protein Kinase Inhibitors
General subdivision therapeutic use.
Topical term or geographic name as entry element Drug Delivery Systems.
Topical term or geographic name as entry element Drug Discovery.
Topical term or geographic name as entry element MEDICAL
General subdivision Pharmacology.
Source of heading or term bisacsh
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Müller, Gerhard.
Personal name Klebl, Bert.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element Wiley InterScience (Online service)
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Title Protein kinases as drug targets.
Place, publisher, and date of publication Weinheim : Wiley-VCH ; Chichester : John Wiley [distributor], ©2011
International Standard Book Number 9783527317905
Record control number (OCoLC)664325820
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Methods and principles in medicinal chemistry ;
Volume number/sequential designation 49.
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://onlinelibrary.wiley.com/book/10.1002/9783527633470">http://onlinelibrary.wiley.com/book/10.1002/9783527633470</a>
Public note Wiley Online Library [Free Download only for SUST IP]
938 ## -
-- Coutts Information Services
-- COUT
-- 19349327
-- EBSCOhost
-- EBSC
-- 398561
-- Ingram Digital eBook Collection
-- IDEB
-- 328324
-- YBP Library Services
-- YANK
-- 7191904
994 ## -
-- 92
-- DG1

No items available.